Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants

Veterinary Parasitology

Volumn 144, Issue 1-2, 2007, Pages 10-19

  Schetters, Th P M ^a   Strydom, T ^b   Crafford, D ^b   Kleuskens, J A G M ^a   van de Crommert, J ^a   Vermeulen, A N ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

^b Malelane Research Unit   (South Africa)

Author keywords

Babesia canis; Babesia rossi; Dogs; Immunity; Nobivac Piro; Soluble parasite antigens; Vaccine

Indexed keywords

CARBESIA; FORRAY 65; IMIDOCARB DIPROPIONATE; PARASITE ANTIGEN; PROTOZOAL VACCINE; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA; BABESIA CANIS; BABESIA ROSSI; BABESIOSIS; BLOOD SMEAR; CHEMOTHERAPY; CONTROLLED STUDY; DOG; ERYTHROCYTE; FEMALE; IMMUNITY; INFECTION PREVENTION; MALE; MORTALITY; NONHUMAN; PARASITEMIA; SUPERNATANT; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BABESIA; BABESIOSIS; DOG DISEASES; DOGS; ERYTHROCYTES; FEMALE; HEMATOCRIT; IMMUNIZATION, SECONDARY; MALE; PARASITEMIA; PROTOZOAN VACCINES; TIME FACTORS;

BABESIA; BABESIA CANIS; BABESIA ROSSI; CANIS FAMILIARIS;

EID: 33846625531     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.09.026     Document Type: Article

References (29)

1. Allred D.R., and Al-Khedery B. Antigenic variation as an exploitable weakness of babesial parasites. Vet. Parasitol. 138 (2006) 50-60
2. Bourdoiseau G. Canine babesiosis in France. Vet. Parasitol. 138 (2006) 118-125
3. Carcy B., Precigout E., Schetters Th., and Gorenflot A. Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet. Parasitol. 138 (2006) 33-49
4. Carson C.A., and Phillips R.S. In: Ristic M., and Kreier J.P. (Eds). Immunologic Response of the Vertebrate Host to Babesia (1981), Babesiosis. Academic Press, New York 411-443
5. Depoix D., Carcy B., Jumas-Bilak E., Pages M., Precigout E., Schetters T.P.M., Ravel C., and Gorenflot A. Chromosome number, genome size and polymorphism of European and South African isolates of large Babesia parasites that infect dogs. Parasitology 125 (2002) 313-321
6. Jacobson L.S. The South African form of severe and complicated canine babesiosis: clinical advances 1994-2004. Vet. Parasitol. 138 (2006) 126-139
7. Jacobson L.S., Lobetti R.G., and Vaughan-Scott T. Blood pressure changes in dogs with babesiosis. J. S. Afr. Vet. Assoc. 71 (2000) 14-20
8. Levy M.G., and Ristic M. Babesia bovis: continuous in vitro cultivation in microaerophilus stationary phase culture. Science 207 (1980) 1218
9. Lewis B.D., Penzhorn B.L., and Lopez-Rebollar L.M. Immune responses to South African Babesia canis and the development of a preliminary vaccine. J.S. Afr. Vet. Assoc. 66 (1995) 61-65
10. Moreau Y., Martinod S., and Fayet G. Epidemiologic and immunoprophylactic aspects of canine babesiosis in France. In: Ristic M. (Ed). Babesiosis of Domestic Animals and Man (1988), CRC Press Inc., Boca Raton, FL 191-196
11. Nuttall G.H.F. Canine piroplasmosis. J. Hyg. 4 (1904) 219-252
12. Reyers F., Leisewitz A.L., Lobetti R.G., Milner R.J., Jacobson L.S., and Van Zyl M. Canine babesiosis in South Africa: more than one disease. Does it serve as a model for falciparum malaria?. Ann. Trop. Med. Parasitol. 92 (1998) 503-511
13. Ristic M., and Montenegro-James S. Immunization against Babesia. In: Ristic M. (Ed). Babesiosis of Domestic Animals and Man (1988), CRC Press Inc., Boca Raton, FL 163-189
14. Schetters Th.P.M., Kleuskens J.A.G.M., Scholtes N.C., and Bos H.J. Vaccination of dogs against Babesia canis infection using parasite antigens derived from in vitro culture. Parasite Immunol. 14 (1992) 295-305
15. Schetters Th.P.M., Kleuskens J.A.G.M., Scholtes N.C., Pasman J.W., and Bos H.J. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis. Vet. Parasitol. 52 (1994) 219-233
16. Schetters Th.P.M., and Montenegro-James S. Vaccines against babesiosis using soluble parasite antigens. Parasitol. Today 11 (1995) 456-462
17. Schetters Th., Kleuskens J., Scholtes N., and Bos H.J. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens. Parasite Immunol. 17 (1995) 215-218
18. Schetters T., Kleuskens J., Scholtes N., Pasman J.W., and Bos H.J. Vaccination of dogs with soluble Babesia canis antigens derived from in vitro cultures is strain specific. Acta Parasitol. Turcica (Suppl.) 20 (1996) 543-550
19. Schetters Th.P.M., Scholtes N.C., Kleuskens J.A.G.M., and Bos H.J. Not peripheral parasitaemia but the level of soluble antigen in plasma correlates with vaccine efficacy against Babesia canis. Parasite Immunol. 18 (1996) 1-6
20. Schetters Th.P.M., Kleuskens J.A.G.M., Scholtes N.C., Pasman J.W., and Goovaerts D. Vaccination of dogs against Babesia canis infection. Vet. Parasitol. 73 (1997) 35-41
21. Schetters Th.P.M., Moubri K., Precigout E., Kleuskens J., Scholtes N.C., and Gorenflot A. Different Babesia canis isolates, different diseases. Parasitology 115 (1997) 485-493
22. Schetters T.P.M., Kleuskens J., Scholtes N., and Gorenflot A. Parasite localisation and dissemination in the Babesia-infected host. Ann. Trop. Med. Parasitol. 92 (1998) 513-519
23. Schetters Th.P.M., Kleuskens J.A.G.M., Scholtes N.C., Gorenflot A., Moubri K., and Vermeulen A.N. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants. Vet. Parasitol. 100 (2001) 75-86
24. Schetters Th. Vaccination against canine babesiosis. Trends Parasitol. 21 (2005) 179-184
25. Schetters Th.P.M., Kleuskens J.A.G.M., Scholtes N.C., Van De Crommert J., Krijnen E., Moubri K., Gorenflot A., and Vermeulen A.N. Onset and duration of immunity against B. canis infection in dogs vaccinated with antigens from culture supernatants. Vet. Parasitol. 138 (2006) 140-146
26. Sibinovic K.H., Sibinovic S., Ristic M., and Cox H.G. Immunogenic properties of babesial serum antigens. J. Parasitol. 53 (1967) 1121-1129
27. Smith R.D., James M.A., Ristic M., Aikawa M., and Vega C. Bovine babesiosis: protection of cattle with culture-derived soluble Babesia bovis antigen. Science 212 (1981) 335
28. Uilenberg G., Franssen F.F.J., Perié N., and Spanjer A.A.M. Three groups of Babesia canis distinguished and a proposal for nomenclature. Vet. Quart. 11 (1989) 33-40
29. Wright I.G., and Goodger B.V. Pathogenesis of babesiosis. In: Ristic M. (Ed). Babesiosis of Domestic Animals and Man (1988), CRC Press Inc., Boca Raton, FL 49-113